Biote (BTMD) Invested Capital (2020 - 2026)

Biote (BTMD) has reported Invested Capital for 7 consecutive years, with -$41.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Invested Capital rose 46.92% year-over-year to -$41.7 million; the TTM figure through Mar 2026 stood at -$41.7 million (up 46.92% YoY), while the FY2025 annual figure was -$52.3 million, up 45.5% from the prior year.
• Invested Capital came in at -$41.7 million for Q1 2026 at Biote, up from -$52.3 million in the prior quarter.
• The five-year high for Invested Capital was $10.7 million in Q1 2022, with the low at -$135.2 million in Q2 2024.
• Average Invested Capital over 5 years is -$64.2 million, with a median of -$64.6 million recorded in 2022.
• The largest YoY upside for Invested Capital was 201.52% in 2022 against a maximum downside of 4674.35% in 2022.
• Year by year, Invested Capital stood at -$52.0 million in 2022, then soared by 41.77% to -$30.3 million in 2023, then sank by 216.71% to -$95.9 million in 2024, then surged by 45.5% to -$52.3 million in 2025, then gained by 20.24% to -$41.7 million in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered -$41.7 million, -$52.3 million, and -$59.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.